

(443) 681-7500



Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
Xcision logo
  • GammaPod
    • The Technology
    • Why GammaPod?
    • GammaPod Locations
  • For Clinicians
    • Clinical Literature
    • Webinars
    • GammaPod Consortium
  • Patients
    • Patient Resources Guide
    • GammaPod Locations
    • Breast Cancer Resources
  • Company
    • About Us
    • Mission & Values
    • Leadership
    • Contact Us
  • News & Events
    • Press Releases & Articles
    • Newsroom
    • Events
  • GammaPod
    • The Technology
    • Why GammaPod?
    • GammaPod Locations
  • For Clinicians
    • Clinical Literature
    • Webinars
    • GammaPod Consortium
  • Patients
    • Patient Resources Guide
    • GammaPod Locations
    • Breast Cancer Resources
  • Company
    • About Us
    • Mission & Values
    • Leadership
    • Contact Us
  • News & Events
    • Press Releases & Articles
    • Newsroom
    • Events

GammaPod Animation

Newsroom

The Doctors

Newsroom

University of Maryland School of Medicine

Newsroom

CBS New York

Newsroom

Innovation Stories from ESTRO 2022 – GammaPod

Newsroom

Medicare physician payment final rule cements more cuts to radiation oncology, underscores need for legislative fix

ASTRO Press Release

November 2, 2023 | ASTRO News The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors, in response to the final 2024 Medicare Physician Fee Schedule...

World’s Largest Medtech Accelerator Announces 61 Startups for its 2023 Cohort

MedTech Innovator Press Release

“The 2023 MedTech Innovator Cohort once again includes passionate medtech entrepreneurs from around the globe. We look forward to working with our corporate partners and industry advisors over the course of the program, to help these startups advance their medical...

Hundred treatments carried out and completed with GammaPod in Udine, Italy

Article

It’s been one year since the press conference which set off the clinical use of GammaPod in Udine. A year of intense work for the staff of the ASUFC Radiotherapy department, which led to the successful completion of the hundredth stereotactic radiotherapy breast...

Xcision Announces Start of Breast Cancer Treatments Using GammaPod™ Stereotactic Radiotherapy System at Leading Italian Hospital

Xcision Press Release

COLUMBIA, Md. (PRWEB) April 12, 2022 Xcision Medical Systems, LLC today announced that Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) in Italy recently began treating patients with the GammaPod™ Stereotactic Radiotherapy System, a breast cancer treatment...

GammaPod Stereotactic Radiotherapy System for Breast Cancer Receives CE Mark

Xcision Press Release

COLUMBIA, Md., April 25, 2019 /PRNewswire/ — Xcision Medical Systems, LLC announced that the GammaPod stereotactic radiotherapy system has received CE marking, paving the way for new sales in Europe and offering patients the latest option in noninvasive breast...
« Older Entries
Next Entries »

Recent Posts

  • Bipartisan bill to modernize radiation oncology reimbursement introduced in Congress
  • Xcision to feature GammaPod – a powerful tool for breast cancer – at ESTRO 2024
  • Minimizing Treatment Fractions for Early-Stage Breast Cancer Patients
  • No Pain, No Anesthesia, No Scars: The Driving Idea to Develop GammaPod
  • Xcision to feature GammaPod™ at Arab Health 2024

Recent Comments

No comments to show.

Contact Info

A 9176 Red Branch Road, Suite O,
Columbia, MD 21045
E info@xcision.com
P (443) 681-7500

Quick Links

  • Contact Xcision
  • GammaPod Locations
  • Breast Cancer Resources
  • Terms Of Use
  • Privacy Policy

Follow Us On Social Media

  • Follow
  • Follow
  • Follow
  • Follow

The GammaPod system has received 510(k) clearance from the US Food and Drug Administration and CE Mark in Europe. Please contact Xcision regarding availability in other markets.

Copyright © 2025 Xcision Medical Systems, LLC